Zobrazeno 1 - 7
of 7
pro vyhledávání: '"R Yu Nasyrova"'
Publikováno v:
Современная онкология, Vol 9, Iss 4, Pp 65-68 (2007)
В ХХI веке разработка лекарств для подавления идентифицированных белков и генов, ответственных за трансформацию клеток и поддержание и
Externí odkaz:
https://doaj.org/article/839a38da318f4fddb39dca3ed349b42e
Autor:
N. S. Besova, T. A. Titova, E. V. Trusilova, V. A. Gorbunova, A. A. Tryakin, O. O. Gordeeva, A. A. Rumyantsev, R. Yu. Nasyrova, L. G. Zhukova, A. V. Snegovoy, E. V. Artamonova, L. V. Manzyuk, A. A. Fedenko
Publikováno v:
Медицинский совет, Vol 0, Iss 10, Pp 34-40 (2018)
Background. Working out of the second line chemotherapy of advanced gastric adenocarcinoma is a promising approach to cancer therapy. Ramucirumab, an anti-angiogenic agent specifically targeting vascular endothelial growth factor receptor-2 (VEGFR-2)
Externí odkaz:
https://doaj.org/article/04195fc596f7418795345774f13af70d
Autor:
N. S. Besova, T. A. Titova, V. A. Gorbunova, O. O. Gordeeva, A. A. Tryakin, A. V. Snegovoy, R. Yu. Nasyrova, A. A. Rumyantsev, E. A. Voroshilova, E. V. Artamonova
Publikováno v:
Медицинский совет, Vol 0, Iss 14, Pp 30-38 (2017)
Angiogenesis has become an important target in the treatment of solid tumors and anti-angiogenic agents are a promising approach to cancer therapy. Ramucirumab, an anti-angiogenic agent specifically targeting vascular endothelial growth factor recept
Externí odkaz:
https://doaj.org/article/c2a7979bf8de497a9de468175d5de089
Autor:
S. A. Kuznetsov, I. Zh. Shubina, L. T. Mamedova, A. N. Gritsay, R. Yu. Nasyrova, M. V. Kiselevsky, V. V. Kuznetsov
Publikováno v:
Опухоли женской репродуктивной системы, Vol 11, Iss 3, Pp 61-66 (2015)
This paper analyzes large amounts of literature data on studies of the efficiency of neoadjuvant chemotherapy (NCT) for advanced ovarian cancer (OC), which is performed prior to standard surgery. Clinical trials have demonstrated that a NCT regimen f
Externí odkaz:
https://doaj.org/article/6406560f1a074c368dab5b1ef44017a2
Autor:
A. M. Garin, R. Yu. Nasyrova
Publikováno v:
Klinicist, Vol 5, Iss 3, Pp 86-94 (2014)
In the review the data on the incidence of lung cancer in Russia and the world is presented. Effectiveness of different screening methods used to identify patients with lung cancer, the value of different diagnostic methods is discussed. The data on
Externí odkaz:
https://doaj.org/article/f2ea02bc6ab14e93b932d5266f174040
Autor:
A.S. Popova, Mona Frolova, Alexey Rumyantsev, R. Yu. Nasyrova, Elena Glazkova, Kh. Kh.-M. Elsnukaeva, Anatoly Bulanov, V.Yu. Fedyanin, Alexandra Tyulyandina, Alexey Tryakin, Ekaterina Ignatova, Marina Stenina, Sergei Tjulandin, Ilya Pokataev, L.V. Chitia, Olga Sekhina
Publikováno v:
Practical oncology. 19:419-427
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b016b572081bd3cd6bd7540c33f86f32
https://doi.org/10.31917/1903419
https://doi.org/10.31917/1903419
Autor:
E. V. Artamonova, R. Yu. Nasyrova, O. O. Gordeeva, N. S. Besova, Alexey Rumyantsev, Alexey Tryakin, E. A. Voroshilova, T. A. Titova, V. A. Gorbunova, A. V. Snegovoy
Publikováno v:
Медицинский совет, Vol 0, Iss 14, Pp 30-38 (2017)
Angiogenesis has become an important target in the treatment of solid tumors and anti-angiogenic agents are a promising approach to cancer therapy. Ramucirumab, an anti-angiogenic agent specifically targeting vascular endothelial growth factor recept
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c3e00b019d97e0385294b723cc0a49a
https://www.med-sovet.pro/jour/article/view/2180
https://www.med-sovet.pro/jour/article/view/2180